PELOBIOTECH GmbH, a leader in the field of biotechnology, announces a strategic partnership with HVD Life Science Vertriebs GmbH to distribute the innovative Poietis’ Next-Gen Bioprinting platform, NGB-RTM in Germany. This strategic partnership is anticipated to set new standards in the field of biotechnological research, providing scientists and researchers in Germany with access to state-of-the-art […]
continue reading
PELOBIOTECH GmbH is happy to announce organizing the first conference "Advancements in Animal-Free Research and Translational Medicine" in Munich/Gräfelfing. Scheduled for June 27, 2024, this conference aims to spotlight novel non-animal approaches vital for progress in translational medical research. The Munich Cell Specialist PELOBIOTECH distributes one of the broadest portfolios of 2D&3D cell culture systems, […]
continue reading
Mit dem Thema „Advanced Therapies – Challenges for Routine Applications“ startet am 17.5.2022 die ATMP im Haus der DECHEMA in Frankfurt. Als einer der weltweit führenden Anbieter tierischer und humaner Zellen & Medien präsentiert das Unternehmen PELOBiotech, aus Planegg bei München, die CellCorTM Linie. Diese, seit knapp einem Jahr in Europa eingeführte, chemisch definierte Medium-Linie […]
continue readingMartinsried – PELOBiotech GmbH, one of the leading Cell Culture solution experts worldwide, is happy to introduce SpheroSeev & HydroSeev, recombinant biopolymers similar to spider silk. They are produced by Seevix, an Israelian biotech company, and can be used together with hydrogels (e.g. Matrigel) to stabilize hydrogels for long-term culture. “As the need for long-term […]
continue reading